These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 18056279)

  • 1. Posaconazole activity against Candida glabrata after exposure to caspofungin or amphotericin B.
    Spreghini E; Maida CM; Milici ME; Scalise G; Barchiesi F
    Antimicrob Agents Chemother; 2008 Feb; 52(2):513-7. PubMed ID: 18056279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posaconazole against Candida glabrata isolates with various susceptibilities to fluconazole.
    Spreghini E; Maida CM; Tomassetti S; Orlando F; Giannini D; Milici ME; Scalise G; Barchiesi F
    Antimicrob Agents Chemother; 2008 Jun; 52(6):1929-33. PubMed ID: 18391037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caspofungin in combination with amphotericin B against Candida glabrata.
    Barchiesi F; Spreghini E; Fothergill AW; Arzeni D; Greganti G; Giannini D; Rinaldi MG; Scalise G
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2546-9. PubMed ID: 15917570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caspofungin in combination with amphotericin B against Candida parapsilosis.
    Barchiesi F; Spreghini E; Tomassetti S; Giannini D; Scalise G
    Antimicrob Agents Chemother; 2007 Mar; 51(3):941-5. PubMed ID: 17158939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Broth microdilution and time-kill testing of Caspofungin, voriconazole, amphotericin B and their combinations against clinical isolates of Candida krusei.
    Oz Y; Dag I; Kiraz N
    Mycopathologia; 2012 Jan; 173(1):27-34. PubMed ID: 21842180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of aminocandin and caspofungin against Candida glabrata including isolates with reduced caspofungin susceptibility.
    Brzankalski GE; Najvar LK; Wiederhold NP; Bocanegra R; Fothergill AW; Rinaldi MG; Pattterson TF; Graybill JR
    J Antimicrob Chemother; 2008 Nov; 62(5):1094-100. PubMed ID: 18658194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: results of a 3-year (2004 to 2007) surveillance study.
    González GM; Elizondo M; Ayala J
    J Clin Microbiol; 2008 Sep; 46(9):2902-5. PubMed ID: 18632907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postantifungal effect of the combination of caspofungin with voriconazole and amphotericin B against clinical Candida krusei isolates.
    Oz Y; Kiremitci A; Dag I; Metintas S; Kiraz N
    Med Mycol; 2013 Jan; 51(1):60-5. PubMed ID: 22746405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multilaboratory testing of two-drug combinations of antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis.
    Chaturvedi V; Ramani R; Andes D; Diekema DJ; Pfaller MA; Ghannoum MA; Knapp C; Lockhart SR; Ostrosky-Zeichner L; Walsh TJ; Marchillo K; Messer S; Welshenbaugh AR; Bastulli C; Iqbal N; Paetznick VL; Rodriguez J; Sein T
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1543-8. PubMed ID: 21282457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal activity of caspofungin in combination with amphotericin B against Candida glabrata: comparison of disk diffusion, Etest, and time-kill methods.
    Kiraz N; Dag I; Yamac M; Kiremitci A; Kasifoglu N; Akgun Y
    Antimicrob Agents Chemother; 2009 Feb; 53(2):788-90. PubMed ID: 19029317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of micafungin, caspofungin, and anidulafungin against a difficult-to-treat fungal opportunistic pathogen, Candida glabrata.
    Spreghini E; Orlando F; Sanguinetti M; Posteraro B; Giannini D; Manso E; Barchiesi F
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1215-22. PubMed ID: 22203604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro pharmacodynamics and in vivo efficacy of fluconazole, amphotericin B and caspofungin in a murine infection by Candida lusitaniae.
    Sandoval-Denis M; Pastor FJ; Capilla J; Sutton DA; Fothergill AW; Guarro J
    Int J Antimicrob Agents; 2014 Feb; 43(2):161-4. PubMed ID: 24360922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the in vitro kinetic activity of caspofungin against Candida glabrata.
    Nagappan V; Boikov D; Vazquez JA
    Antimicrob Agents Chemother; 2010 Jan; 54(1):522-5. PubMed ID: 19841143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the fungicidal activities of caspofungin and amphotericin B against Candida glabrata.
    Barchiesi F; Spreghini E; Tomassetti S; Arzeni D; Giannini D; Scalise G
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4989-92. PubMed ID: 16304162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The activity of echinocandins, amphotericin B and voriconazole against fluconazole-susceptible and fluconazole-resistant Brazilian Candida glabrata isolates.
    Mario DA; Denardi LB; Bandeira LA; Antunes MS; Santurio JM; Severo LC; Alves SH
    Mem Inst Oswaldo Cruz; 2012 May; 107(3):433-6. PubMed ID: 22510843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the kidney fungal burden in experimental disseminated candidiasis by species of the Candida parapsilosis complex treated with fluconazole, amphotericin B and caspofungin in a temporarily neutropenic murine model.
    Szilágyi J; Földi R; Gesztelyi R; Bayegan S; Kardos G; Juhász B; Majoros L
    Chemotherapy; 2012; 58(2):159-64. PubMed ID: 22626860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamics of echinocandins against Candida glabrata: requirement for dosage escalation to achieve maximal antifungal activity in neutropenic hosts.
    Howard SJ; Livermore J; Sharp A; Goodwin J; Gregson L; Alastruey-Izquierdo A; Perlin DS; Warn PA; Hope WW
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4880-7. PubMed ID: 21807969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of antifungal combinations against Candida albicans biofilms.
    Tobudic S; Kratzer C; Lassnigg A; Graninger W; Presterl E
    J Antimicrob Chemother; 2010 Feb; 65(2):271-4. PubMed ID: 19996142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amphotericin B and caspofungin resistance in Candida glabrata isolates recovered from a critically ill patient.
    Krogh-Madsen M; Arendrup MC; Heslet L; Knudsen JD
    Clin Infect Dis; 2006 Apr; 42(7):938-44. PubMed ID: 16511756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo antifungal susceptibilities of the Mucoralean fungus Cunninghamella.
    Pastor FJ; Ruíz-Cendoya M; Pujol I; Mayayo E; Sutton DA; Guarro J
    Antimicrob Agents Chemother; 2010 Nov; 54(11):4550-5. PubMed ID: 20805397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.